We are live on
!
Find out more
Cetera Investment Advisers Portfolio holdings
AUM
$94B
1-Year Est. Return
20.14%
This Fund
S&P 500
This Quarter
Est. Return
+6.19%
1 Year Est. Return
+20.14%
3 Year Est. Return
+58.25%
5 Year Est. Return
+64.18%
10 Year Est. Return
+205.32%
AUM
$45.7B
AUM Growth
+$2.29B
(+5.3%)
Cap. Flow
-$104M
Cap. Flow
% of AUM
-0.23%
Top 10 Holdings %
Top 10 Hldgs %
16.82%
Holding
3,957
New
233
Increased
1,887
Reduced
1,511
Closed
243
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core US Aggregate Bond ETF
AGG
|
+$164M |
| 2 |
Federated Hermes Total Return Bond ETF
FTRB
|
+$88.1M |
| 3 |
iShares Core Universal USD Bond ETF
IUSB
|
+$83.9M |
| 4 |
iShares MSCI EAFE Value ETF
EFV
|
+$72.5M |
| 5 |
T. Rowe Price Blue Chip Growth ETF
TCHP
|
+$36.9M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Invesco QQQ Trust
QQQ
|
+$788M |
| 2 |
First Trust Capital Strength ETF
FTCS
|
+$128M |
| 3 |
BondBloxx Bloomberg Six Month Target Duration US Treasury ETF
XHLF
|
+$121M |
| 4 |
State Street SPDR Bloomberg 1-3 Month T-Bill ETF
BIL
|
+$101M |
| 5 |
iShares Core S&P 500 ETF
IVV
|
+$58.9M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 10.56% |
| 2 | Financials | 4.21% |
| 3 | Consumer Discretionary | 3.68% |
| 4 | Healthcare | 3.44% |
| 5 | Industrials | 2.99% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3601
Lexicon Pharmaceuticals
LXRX
$1.07B
| $34.2K | ﹤0.01% |
+21,775
| New | +$38.8K |
|
|
SLI
3602
Standard Lithium
SLI
$623M
| $34.1K | ﹤0.01% |
21,482
+500
| +2% | +$644 |
|
3603
Gevo
GEVO
$388M
| $33.3K | ﹤0.01% |
20,428
+1,800
| +10% | +$1.46K |
|
|
PLG
3604
Platinum Group Metals
PLG
$203M
| $32.8K | ﹤0.01% |
22,969
-359
| -2% | -$526 |
|
|
LAZR
3605
DELISTED
Luminar Technologies
LAZR
| $32.4K | ﹤0.01% |
2,398
-202
| -8% | -$3.67K |
|
3606
Stem
STEM
$50.9M
| $32.3K | ﹤0.01% |
4,637
-112
| -2% | -$1.76K |
|
3607
Blink Charging
BLNK
$86.7M
| $31.2K | ﹤0.01% |
18,150
-1,140
| -6% | -$2.72K |
|
3608
Heron Therapeutics
HRTX
$63.4M
| $30.4K | ﹤0.01% |
15,256
+147
| +1% | +$351 |
|
3609
Caribou Biosciences
CRBU
$165M
| $30.2K | ﹤0.01% |
15,423
+2,480
| +19% | +$5.08K |
|
|
AMLI
3610
DELISTED
American Lithium Corp. Common Stock
AMLI
| $29.9K | ﹤0.01% |
52,714
+2,000
| +4% | +$897 |
|
3611
Polestar Automotive Holding UK
PSNY
$2.01B
| $27.5K | ﹤0.01% |
532
+1
| +0.2% | +$32 |
|
3612
Fortress Biotech
FBIO
$91.4M
| $27.4K | ﹤0.01% |
18,989
+2,223
| +13% | +$4.23K |
|
3613
CALL
NVIDIA
NVDA
$5.27T
| $27.4K | ﹤0.01% |
+8,500
| New | +$1M |
|
|
SAVE
3614
DELISTED
Spirit Airlines, Inc.
SAVE
| $26.5K | ﹤0.01% |
+11,044
| New | +$30.4K |
|
|
BPT
3615
DELISTED
BP Prudhoe Bay Royalty Trust
BPT
| $26.5K | ﹤0.01% |
24,495
+49
| +0.2% | +$84 |
|
|
BGDE
3616
Big Digital Energy Inc
BGDE
$31.1M
| $26K | ﹤0.01% |
+1,050
| New | +$28.4K |
|
|
ESPR
3617
DELISTED
Esperion Therapeutics
ESPR
| $25.8K | ﹤0.01% |
15,625
+96
| +0.6% | +$194 |
|
3618
Microvision
MVIS
$88.5M
| $24.8K | ﹤0.01% |
1,453
-5
| -0.3% | -$78 |
|
|
JFU
3619
9F Inc
JFU
$28M
| $24.4K | ﹤0.01% |
10,100
-1,100
| -10% | -$2.01K |
|
|
GOEV
3620
DELISTED
Canoo Inc. Class A Common Stock
GOEV
| $24.1K | ﹤0.01% |
+1,227
| New | +$41.2K |
|
3621
Heartbeam
BEAT
$30.5M
| $24.1K | ﹤0.01% |
+10,400
| New | +$25.1K |
|
3622
GlucoTrack
GCTK
$3.11M
| $24.1K | ﹤0.01% |
8
| – | – |
|
3623
Compugen
CGEN
$221M
| $23.5K | ﹤0.01% |
12,980
-401
| -3% | -$732 |
|
|
VXRT
3624
DELISTED
Vaxart
VXRT
| $22.7K | ﹤0.01% |
26,690
-1,750
| -6% | -$1.34K |
|
3625
Senseonics Holdings Inc
SENS
$399M
| $20.6K | ﹤0.01% |
2,950
-5
| -0.2% | -$40 |
|
Similar funds
Cetera Investment Advisers's Q3 2024 Portfolio in Review
As of Q3 2024, Cetera Investment Advisers held 3,957 positions worth $45.7B, up 5.3% from $43.4B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
Cetera Investment Advisers's Q3 2024 filing shows 233 new, 1,887 increased, 1,511 reduced and 243 closed positions. Its largest new stake was JPMorgan Active Bond ETF: 81,968 shares worth $4.48M. The largest sale was Invesco QQQ Trust, an estimated $788M.
By sector, the portfolio is most concentrated in Technology at 11% of assets, down from 11% a quarter earlier, followed by Financials and Consumer Discretionary.
- Cetera Investment Advisers's largest Q3 2024 buy was JPMorgan Active Bond ETF: 81,968 shares worth $4.48M.
- Cetera Investment Advisers added most to iShares Core US Aggregate Bond ETF in Q3 2024, an estimated $164M increase.
- Cetera Investment Advisers's biggest Q3 2024 reduction was State Street SPDR Bloomberg 1-3 Month T-Bill ETF, cutting an estimated $101M.
- Cetera Investment Advisers fully exited Invesco QQQ Trust in Q3 2024, selling an estimated $788M.
- Cetera Investment Advisers's ten largest holdings make up 17% of its $45.7B portfolio in Q3 2024.
- Cetera Investment Advisers opened 233 new positions and closed 243 in Q3 2024.
- Cetera Investment Advisers's portfolio value rose 5.3% quarter-over-quarter to $45.7B.
Based on Cetera Investment Advisers's 13F filing for Q3 2024, filed 13 Nov 2024.